Nectar Lifesciences Ltd

NSE: NECLIFE · BSE: 532649 · Pharmaceuticals & Biotechnology · 23 announcements

Share price: ₹10.65
Market cap: ₹238.8 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹-292.9 Cr
P/E (TTM): -1.0×Sector 47.4×
Promoter holding: 51.84%+0.00% QoQ
FII holding: 0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 4 Financial Results 4 Merger & Restructuring 3 Business Update 2 Board Meeting Date 2 Annual General Meeting 2 Legal & Regulatory 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

28 Apr 2026 13:20 IST BSE

Legal & Regulatory

Nectar Lifesciences Legal & Regulatory

Nectar Lifesciences Ltd announced the conclusion of income tax litigation for Assessment Year 2017-18. Following directions from the Punjab and Haryana High Court, the Deputy Commissioner of Income Tax passed an order in favor of the company on March 31, 2026. The matter stands fully concluded with no financial implications or claims.

Read the filing ↗